CLINICAL_TRIALS
trial_result
· 2017-08-07
Clinical Trial Update: A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin [Phase 2]
Summary
Pfizer reports results from a 12-week Phase 2 trial evaluating PF-06291874 once daily in adults with type 2 diabetes mellitus inadequately controlled on metform…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-08-07